Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.
Causes of death
diabetes mellitus
mortality
opiate addiction
opioids
opium
Journal
International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871
Informations de publication
Date de publication:
03 03 2021
03 03 2021
Historique:
accepted:
23
06
2020
pubmed:
19
8
2020
medline:
3
6
2021
entrez:
19
8
2020
Statut:
ppublish
Résumé
Many diabetic individuals use prescription and non-prescription opioids and opiates. We aimed to investigate the joint effect of diabetes and opiate use on all-cause and cause-specific mortality. Golestan Cohort study is a prospective population-based study in Iran. A total of 50 045 people-aged 40-75, 28 811 women, 8487 opiate users, 3548 diabetic patients-were followed during a median of 11.1 years, with over 99% success follow-up. Hazard ratio and 95% confidence intervals (HRs, 95% CIs), and preventable death attributable to each risk factor, were calculated. After 533 309 person-years, 7060 deaths occurred: 4178 (10.8%) of non-diabetic non-opiate users, 757 (25.3%) diabetic non-users, 1906 (24.0%) non-diabetic opiate users and 219 (39.8%) diabetic opiate users. Compared with non-diabetic non-users, HRs (95% CIs) for all-cause mortality were 2.17 (2.00-2.35) in diabetic non-opiate users, 1.63 (1.53-1.74) in non-diabetic opiate users and 2.76 (2.40-3.17) in diabetic opiate users. Among those who both had diabetes and used opiates, 63.8% (95% CI: 58.3%-68.5%) of all deaths were attributable to these risk factors, compared with 53.9% (95% CI: 50%-57.4%) in people who only had diabetes and 38.7% (95% CI: 34.6%-42.5%) in non-diabetic opiate users. Diabetes was more strongly associated with cardiovascular than cancer mortality. The risk of early mortality in known cases of diabetes did not depend on whether they started opiate use before or after their diagnosis. Using opiates is detrimental to the health of diabetic patients. Public awareness about the health effects of opiates, and improvement of diabetes care especially among individuals with or at risk of opiate use, are necessary.
Sections du résumé
BACKGROUND
Many diabetic individuals use prescription and non-prescription opioids and opiates. We aimed to investigate the joint effect of diabetes and opiate use on all-cause and cause-specific mortality.
METHODS
Golestan Cohort study is a prospective population-based study in Iran. A total of 50 045 people-aged 40-75, 28 811 women, 8487 opiate users, 3548 diabetic patients-were followed during a median of 11.1 years, with over 99% success follow-up. Hazard ratio and 95% confidence intervals (HRs, 95% CIs), and preventable death attributable to each risk factor, were calculated.
RESULTS
After 533 309 person-years, 7060 deaths occurred: 4178 (10.8%) of non-diabetic non-opiate users, 757 (25.3%) diabetic non-users, 1906 (24.0%) non-diabetic opiate users and 219 (39.8%) diabetic opiate users. Compared with non-diabetic non-users, HRs (95% CIs) for all-cause mortality were 2.17 (2.00-2.35) in diabetic non-opiate users, 1.63 (1.53-1.74) in non-diabetic opiate users and 2.76 (2.40-3.17) in diabetic opiate users. Among those who both had diabetes and used opiates, 63.8% (95% CI: 58.3%-68.5%) of all deaths were attributable to these risk factors, compared with 53.9% (95% CI: 50%-57.4%) in people who only had diabetes and 38.7% (95% CI: 34.6%-42.5%) in non-diabetic opiate users. Diabetes was more strongly associated with cardiovascular than cancer mortality. The risk of early mortality in known cases of diabetes did not depend on whether they started opiate use before or after their diagnosis.
CONCLUSIONS
Using opiates is detrimental to the health of diabetic patients. Public awareness about the health effects of opiates, and improvement of diabetes care especially among individuals with or at risk of opiate use, are necessary.
Identifiants
pubmed: 32810213
pii: 5894042
doi: 10.1093/ije/dyaa126
pmc: PMC7938504
doi:
Substances chimiques
Analgesics, Opioid
0
Opiate Alkaloids
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
314-324Subventions
Organisme : Cancer Research UK
ID : C20/A5860
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : UL1 GM118973
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
Published by Oxford University Press on behalf of the International Epidemiological Association 2020. This work is written by US Government employees and is in the public domain in the US.
Références
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Front Physiol. 2016 Oct 13;7:436
pubmed: 27790151
Diabetologia. 1988 Dec;31(12):889-91
pubmed: 3240844
Diabetes Care. 2017 Jan;40(1):136-154
pubmed: 27999003
Diabetes Metab. 2009 Jun;35(3):206-13
pubmed: 19297223
Pain Med. 2015 Nov;16(11):2075-83
pubmed: 26118704
Mol Cell Biol. 2003 Sep;23(17):6255-66
pubmed: 12917346
Endocr Rev. 2010 Feb;31(1):98-132
pubmed: 19903933
J Diabetes Complications. 2015 Jul;29(5):644-9
pubmed: 25922309
Diabet Med. 2004 Sep;21(9):976-82
pubmed: 15317601
Eur J Pain. 2007 Aug;11(6):652-64
pubmed: 17126045
N Engl J Med. 2016 Apr 14;374(15):1455-64
pubmed: 27074068
Curr Med Res Opin. 2010 Feb;26(2):337-43
pubmed: 19968592
Int J Epidemiol. 2009 Aug;38(4):978-88
pubmed: 19416955
PLoS One. 2011;6(10):e26725
pubmed: 22053206
Am J Drug Alcohol Abuse. 2008;34(4):383-8
pubmed: 18584567
Arch Iran Med. 2016 Dec;19(12):870-876
pubmed: 27998163
Eur J Clin Nutr. 2006 Aug;60(8):971-7
pubmed: 16465196
N Engl J Med. 2016 Nov 17;375(20):1961-1971
pubmed: 27959614
N Engl J Med. 2011 Mar 03;364(9):829-841
pubmed: 21366474
Cell Death Dis. 2018 Apr 22;9(6):671
pubmed: 29867095
Am J Public Health. 1998 Jan;88(1):15-9
pubmed: 9584027
Int J Cardiol. 2010 May 14;141(1):116-8
pubmed: 19346018
PLoS One. 2010 Jun 17;5(6):e11183
pubmed: 20567597
J Diabetes. 2015 Sep;7(5):613-21
pubmed: 25042896
Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):650-658
pubmed: 31915141
Am J Manag Care. 2009 Apr;15(4):217-24
pubmed: 19355794
Clin J Pain. 2015 May;31(5):414-24
pubmed: 25853725
Pharmazie. 2007 Sep;62(9):717-20
pubmed: 17944329
Addiction. 1997 Mar;92(3):267-77
pubmed: 9219389
Lancet. 2018 Jun 16;391(10138):2430-2440
pubmed: 29784146
Int J Epidemiol. 2010 Feb;39(1):52-9
pubmed: 19332502
Drug Alcohol Depend. 2015 Nov 1;156:162-169
pubmed: 26392231
Nat Rev Cardiol. 2013 Dec;10(12):733-40
pubmed: 24145895
Arch Iran Med. 2013 Mar;16(3):154-60
pubmed: 23432167
Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):1068-70
pubmed: 15184266
BMJ. 2012 Apr 17;344:e2502
pubmed: 22511302
J Diabetes Complications. 2015 Jan-Feb;29(1):146-56
pubmed: 25239450
Curr Diab Rep. 2017 Jan;17(1):2
pubmed: 28101793
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
Lancet Oncol. 2014 Feb;15(2):e69-77
pubmed: 24480557
Psychiatr Serv. 2011 Jun;62(6):659-65
pubmed: 21632736